Laura Fenton
Concepts (353)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 22 | 2024 | 3566 | 1.180 |
Why?
| | Entorhinal Cortex | 1 | 2024 | 13 | 0.900 |
Why?
| | Brain Stem Neoplasms | 5 | 2015 | 83 | 0.800 |
Why?
| | Tomography, X-Ray Computed | 11 | 2014 | 2691 | 0.710 |
Why?
| | Scrotum | 2 | 2016 | 27 | 0.690 |
Why?
| | Neuroimaging | 1 | 2022 | 259 | 0.660 |
Why?
| | Brain | 6 | 2022 | 2668 | 0.590 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 383 | 0.550 |
Why?
| | Ganglioglioma | 2 | 2015 | 35 | 0.550 |
Why?
| | Esophagus | 3 | 2015 | 255 | 0.530 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 278 | 0.530 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 12 | 0.490 |
Why?
| | Brain Diseases | 2 | 2019 | 141 | 0.480 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 325 | 0.480 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 54 | 0.470 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 63 | 0.410 |
Why?
| | Osteitis | 1 | 2013 | 2 | 0.410 |
Why?
| | Eosinophils | 1 | 2015 | 332 | 0.400 |
Why?
| | Child | 34 | 2024 | 21935 | 0.400 |
Why?
| | Ultrasonography | 3 | 2016 | 759 | 0.400 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 294 | 0.390 |
Why?
| | Glioma | 2 | 2009 | 395 | 0.380 |
Why?
| | Child, Preschool | 24 | 2019 | 11074 | 0.380 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 224 | 0.370 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 95 | 0.370 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 23 | 0.370 |
Why?
| | Gastritis | 1 | 2013 | 108 | 0.370 |
Why?
| | Enteritis | 1 | 2013 | 103 | 0.360 |
Why?
| | Radiography | 8 | 2016 | 822 | 0.350 |
Why?
| | Eosinophilia | 1 | 2013 | 218 | 0.340 |
Why?
| | Infant | 21 | 2019 | 9465 | 0.330 |
Why?
| | Male | 43 | 2024 | 67762 | 0.330 |
Why?
| | Liver Neoplasms | 3 | 2008 | 786 | 0.330 |
Why?
| | Radiation Injuries | 2 | 2019 | 145 | 0.330 |
Why?
| | Colitis | 1 | 2013 | 266 | 0.320 |
Why?
| | Diagnosis, Differential | 9 | 2024 | 1483 | 0.320 |
Why?
| | Spinal Fusion | 1 | 2013 | 251 | 0.320 |
Why?
| | Female | 46 | 2024 | 73304 | 0.300 |
Why?
| | Humans | 61 | 2024 | 137585 | 0.290 |
Why?
| | Nervous System Diseases | 1 | 2011 | 266 | 0.290 |
Why?
| | Pamphlets | 1 | 2007 | 23 | 0.270 |
Why?
| | Adolescent | 25 | 2024 | 21513 | 0.270 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1946 | 0.260 |
Why?
| | Astrocytoma | 2 | 2007 | 128 | 0.260 |
Why?
| | Deglutition Disorders | 2 | 2020 | 143 | 0.260 |
Why?
| | Mutation | 3 | 2014 | 3958 | 0.250 |
Why?
| | Decision Making | 2 | 2024 | 900 | 0.250 |
Why?
| | Radiation Dosage | 1 | 2007 | 179 | 0.240 |
Why?
| | Infant, Newborn | 16 | 2019 | 6079 | 0.240 |
Why?
| | Stroke | 3 | 2022 | 1120 | 0.240 |
Why?
| | Reproducibility of Results | 6 | 2015 | 3284 | 0.240 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 24 | 0.230 |
Why?
| | Brain Neoplasms | 3 | 2012 | 1238 | 0.230 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 362 | 0.220 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 10 | 0.210 |
Why?
| | Scurvy | 1 | 2024 | 17 | 0.210 |
Why?
| | Retrospective Studies | 14 | 2024 | 15657 | 0.210 |
Why?
| | Venous Thrombosis | 2 | 2016 | 190 | 0.210 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 66 | 0.200 |
Why?
| | Encephalocele | 1 | 2022 | 10 | 0.200 |
Why?
| | Cerebral Cortex | 2 | 2019 | 433 | 0.200 |
Why?
| | Testicular Hydrocele | 1 | 2002 | 4 | 0.200 |
Why?
| | Brain Stem | 1 | 2003 | 94 | 0.190 |
Why?
| | Neuroblastoma | 2 | 2010 | 160 | 0.190 |
Why?
| | Teratoma | 1 | 2003 | 114 | 0.190 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 99 | 0.190 |
Why?
| | Diagnostic Errors | 1 | 2003 | 170 | 0.190 |
Why?
| | Neurofibroma, Plexiform | 1 | 2001 | 9 | 0.180 |
Why?
| | Independent Living | 1 | 2023 | 105 | 0.180 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2001 | 25 | 0.180 |
Why?
| | Abdomen | 1 | 2002 | 125 | 0.180 |
Why?
| | Mesentery | 1 | 2001 | 48 | 0.180 |
Why?
| | Aging | 2 | 2024 | 1864 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 97 | 0.180 |
Why?
| | Child Abuse | 2 | 2012 | 535 | 0.180 |
Why?
| | Parietal Bone | 1 | 2000 | 8 | 0.180 |
Why?
| | Connective Tissue | 1 | 2000 | 36 | 0.170 |
Why?
| | Peritoneal Neoplasms | 1 | 2001 | 93 | 0.170 |
Why?
| | Skull Fractures | 1 | 2000 | 36 | 0.170 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 21 | 0.170 |
Why?
| | Educational Status | 1 | 2023 | 470 | 0.170 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.170 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 85 | 0.170 |
Why?
| | Radiotherapy | 2 | 2019 | 201 | 0.160 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 51 | 0.160 |
Why?
| | Prognosis | 5 | 2014 | 4030 | 0.160 |
Why?
| | Intestine, Small | 1 | 2000 | 156 | 0.150 |
Why?
| | Bevacizumab | 1 | 2019 | 138 | 0.150 |
Why?
| | Corpus Callosum | 1 | 2019 | 71 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1329 | 0.150 |
Why?
| | Parents | 1 | 2007 | 1347 | 0.150 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 51 | 0.150 |
Why?
| | Esophagoscopy | 2 | 2020 | 209 | 0.150 |
Why?
| | Disease-Free Survival | 2 | 2014 | 686 | 0.140 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 178 | 0.140 |
Why?
| | tau Proteins | 1 | 2019 | 90 | 0.140 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 135 | 0.140 |
Why?
| | Fatty Liver | 2 | 2012 | 243 | 0.140 |
Why?
| | Fatal Outcome | 4 | 2016 | 303 | 0.140 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 229 | 0.140 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 240 | 0.140 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1692 | 0.130 |
Why?
| | Moyamoya Disease | 1 | 2017 | 20 | 0.130 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 156 | 0.130 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.130 |
Why?
| | White Matter | 1 | 2019 | 145 | 0.130 |
Why?
| | Hyperammonemia | 1 | 2016 | 16 | 0.130 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 8 | 0.130 |
Why?
| | Treatment Outcome | 8 | 2014 | 10811 | 0.130 |
Why?
| | Multimodal Imaging | 2 | 2019 | 113 | 0.130 |
Why?
| | Young Adult | 6 | 2015 | 13209 | 0.130 |
Why?
| | Cognition | 1 | 2024 | 1153 | 0.130 |
Why?
| | Leigh Disease | 2 | 2013 | 21 | 0.130 |
Why?
| | Aged | 4 | 2024 | 23961 | 0.130 |
Why?
| | Stomach | 1 | 1996 | 110 | 0.130 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 17 | 0.130 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.120 |
Why?
| | Cerebral Veins | 1 | 2016 | 16 | 0.120 |
Why?
| | Vascular Malformations | 1 | 2016 | 52 | 0.120 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 16 | 0.120 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.120 |
Why?
| | Contrast Media | 3 | 2019 | 467 | 0.120 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 399 | 0.120 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 89 | 0.120 |
Why?
| | Cerebral Infarction | 1 | 2015 | 44 | 0.120 |
Why?
| | Portal Vein | 1 | 2016 | 120 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2023 | 951 | 0.120 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 197 | 0.120 |
Why?
| | Temporal Lobe | 1 | 2015 | 91 | 0.120 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 82 | 0.120 |
Why?
| | Abdominal Pain | 2 | 2011 | 145 | 0.120 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.110 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7635 | 0.110 |
Why?
| | Carotid Stenosis | 1 | 2015 | 91 | 0.110 |
Why?
| | Spasm | 1 | 2013 | 20 | 0.110 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2019 | 560 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 47 | 0.100 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.100 |
Why?
| | Pons | 1 | 2012 | 26 | 0.100 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 200 | 0.090 |
Why?
| | Accidents | 1 | 2012 | 37 | 0.090 |
Why?
| | Athletic Injuries | 2 | 2016 | 529 | 0.090 |
Why?
| | Splenomegaly | 1 | 2011 | 15 | 0.090 |
Why?
| | Craniotomy | 1 | 2012 | 77 | 0.090 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 153 | 0.090 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 13 | 0.090 |
Why?
| | Necrosis | 3 | 2019 | 246 | 0.090 |
Why?
| | Decompression, Surgical | 1 | 2012 | 106 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 173 | 0.090 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.090 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 8 | 0.090 |
Why?
| | Anticoagulants | 1 | 2015 | 664 | 0.080 |
Why?
| | Scoliosis | 1 | 2013 | 215 | 0.080 |
Why?
| | Liver Diseases | 2 | 2010 | 315 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 270 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 611 | 0.080 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 92 | 0.080 |
Why?
| | Recurrence | 3 | 2022 | 1060 | 0.080 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 91 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 87 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 83 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 57 | 0.080 |
Why?
| | Optic Neuritis | 1 | 2009 | 41 | 0.080 |
Why?
| | Facial Bones | 1 | 2009 | 30 | 0.080 |
Why?
| | Facial Injuries | 1 | 2009 | 21 | 0.070 |
Why?
| | Autopsy | 2 | 2016 | 95 | 0.070 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 152 | 0.070 |
Why?
| | Liver | 2 | 2016 | 1943 | 0.070 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 24 | 0.070 |
Why?
| | Medulloblastoma | 1 | 2010 | 193 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 318 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 201 | 0.070 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 98 | 0.070 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 73 | 0.070 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 64 | 0.070 |
Why?
| | Biopsy | 2 | 2010 | 1129 | 0.070 |
Why?
| | Meningomyelocele | 1 | 2008 | 59 | 0.070 |
Why?
| | Lung Diseases | 1 | 2014 | 767 | 0.070 |
Why?
| | Craniopharyngioma | 1 | 2009 | 74 | 0.070 |
Why?
| | Aneuploidy | 1 | 2008 | 89 | 0.070 |
Why?
| | Middle Aged | 4 | 2024 | 33479 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 124 | 0.070 |
Why?
| | Obesity | 2 | 2012 | 2992 | 0.070 |
Why?
| | Glioblastoma | 1 | 2010 | 345 | 0.070 |
Why?
| | Brain Injuries | 1 | 2012 | 494 | 0.060 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 366 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 189 | 0.060 |
Why?
| | Vascular Diseases | 1 | 2009 | 243 | 0.060 |
Why?
| | Adult | 8 | 2019 | 37929 | 0.060 |
Why?
| | Brain Ischemia | 1 | 2009 | 338 | 0.060 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Mucormycosis | 1 | 2005 | 22 | 0.060 |
Why?
| | Osteoporosis | 1 | 2008 | 243 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2008 | 263 | 0.060 |
Why?
| | Bone Density | 1 | 2008 | 489 | 0.060 |
Why?
| | Meninges | 1 | 2024 | 43 | 0.050 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 354 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2016 | 5131 | 0.050 |
Why?
| | Meningitis | 1 | 2024 | 79 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2019 | 956 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2024 | 100 | 0.050 |
Why?
| | Carboplatin | 1 | 2003 | 144 | 0.050 |
Why?
| | Vincristine | 1 | 2003 | 116 | 0.050 |
Why?
| | Sinusitis | 1 | 2005 | 221 | 0.050 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 35 | 0.050 |
Why?
| | Risk Factors | 5 | 2012 | 10388 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 177 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 26 | 0.050 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 15 | 0.050 |
Why?
| | Pilot Projects | 2 | 2019 | 1710 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 938 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2009 | 871 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 285 | 0.050 |
Why?
| | Colorado | 4 | 2015 | 4565 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 37 | 0.040 |
Why?
| | Neurofibromatosis 1 | 1 | 2001 | 52 | 0.040 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 9 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 35 | 0.040 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 5472 | 0.040 |
Why?
| | Dilatation | 1 | 2020 | 67 | 0.040 |
Why?
| | Herpes Simplex | 1 | 2000 | 95 | 0.040 |
Why?
| | Enema | 1 | 2000 | 47 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2000 | 169 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 64 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1077 | 0.040 |
Why?
| | Neck | 1 | 2019 | 101 | 0.040 |
Why?
| | Ependymoma | 1 | 2001 | 165 | 0.040 |
Why?
| | Carbolines | 1 | 2019 | 32 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 91 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2837 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 123 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 184 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 4149 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 2031 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2019 | 102 | 0.040 |
Why?
| | Cohort Studies | 3 | 2016 | 5742 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 477 | 0.040 |
Why?
| | Pregnancy | 5 | 2012 | 6763 | 0.030 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.030 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 19 | 0.030 |
Why?
| | Dexamethasone | 1 | 2019 | 368 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2017 | 109 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 39 | 0.030 |
Why?
| | Phenotype | 2 | 2019 | 3196 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 92 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 580 | 0.030 |
Why?
| | Florida | 1 | 2015 | 107 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2017 | 165 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2015 | 77 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 594 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 282 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 343 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1236 | 0.030 |
Why?
| | Hemorrhage | 2 | 2015 | 722 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 322 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 12 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 332 | 0.020 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 3 | 0.020 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 3 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 514 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 6828 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2844 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 186 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 62 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3556 | 0.020 |
Why?
| | Karyotyping | 1 | 2010 | 104 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2012 | 190 | 0.020 |
Why?
| | Anemia | 1 | 1972 | 170 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 189 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 64 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 98 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 104 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3715 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 1139 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 15 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 16 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 684 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 57 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 184 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 767 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 110 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 173 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 327 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 61 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 518 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 653 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 910 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 518 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 259 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 253 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 248 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 294 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 358 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 410 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 203 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2181 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2139 | 0.020 |
Why?
| | Mucor | 1 | 2005 | 7 | 0.020 |
Why?
| | Telencephalon | 1 | 2005 | 16 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2005 | 19 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1972 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2900 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 524 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1738 | 0.010 |
Why?
| | Orbit | 1 | 2005 | 70 | 0.010 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 80 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1396 | 0.010 |
Why?
| | Prospective Studies | 2 | 2009 | 7604 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2804 | 0.010 |
Why?
| | Cleft Lip | 1 | 2003 | 52 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 68 | 0.010 |
Why?
| | United States | 1 | 2019 | 14841 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 17 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 31 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 158 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1786 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 220 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 202 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3457 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 389 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 108 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2389 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 180 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 2186 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 130 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 1007 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 10 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 1079 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 113 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 123 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 5 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 16 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 12 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 61 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 108 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 72 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 108 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 514 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 405 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 2069 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1975 | 27 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 85 | 0.000 |
Why?
| | Blood | 1 | 1975 | 107 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 156 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 97 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 108 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 182 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1199 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|